Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Invested Capital (2019 - 2025)

Pulmonx has reported Invested Capital over the past 7 years, most recently at $91.0 million for Q4 2025.

  • Quarterly Invested Capital fell 25.84% to $91.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $91.0 million through Dec 2025, down 25.84% year-over-year, with the annual reading at $91.0 million for FY2025, 25.84% down from the prior year.
  • Invested Capital was $91.0 million for Q4 2025 at Pulmonx, down from $97.2 million in the prior quarter.
  • Over five years, Invested Capital peaked at $233.5 million in Q1 2021 and troughed at $91.0 million in Q4 2025.
  • The 5-year median for Invested Capital is $166.9 million (2022), against an average of $162.5 million.
  • Year-over-year, Invested Capital soared 220.32% in 2021 and then decreased 25.92% in 2025.
  • A 5-year view of Invested Capital shows it stood at $210.1 million in 2021, then fell by 18.67% to $170.9 million in 2022, then dropped by 9.2% to $155.2 million in 2023, then fell by 20.92% to $122.7 million in 2024, then fell by 25.84% to $91.0 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Invested Capital are $91.0 million (Q4 2025), $97.2 million (Q3 2025), and $106.2 million (Q2 2025).